Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
61.38 GBX | -0.20% | +2.64% | +18.04% |
Mar. 19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
Mar. 19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Sales 2024 * | 27.11M 33.73M | Sales 2025 * | 31.03M 38.61M | Capitalization | 43.3M 53.88M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 2.62M 3.26M | Net Debt 2025 * | 3.84M 4.78M | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-366
x | P/E ratio 2025 * |
147
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.9% |
1 day | -0.20% | ||
1 week | +2.64% | ||
Current month | -1.79% | ||
1 month | -1.00% | ||
3 months | +4.03% | ||
6 months | +12.62% | ||
Current year | +18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 09-12-31 |
David Cocke
DFI | Director of Finance/CFO | 58 | 21-01-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 21-01-04 |
George Phillips
BRD | Director/Board Member | 64 | 21-01-04 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 61.38 | -0.20% | 7 621 |
24-04-23 | 61.5 | 0.00% | 19,970 |
24-04-22 | 61.5 | 0.00% | 15,013 |
24-04-19 | 61.5 | 0.00% | 23,744 |
24-04-18 | 61.5 | +2.84% | 118 |
Delayed Quote London S.E., April 24, 2024 at 05:25 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.04% | 53.87M | |
+4.46% | 32.45B | |
+12.62% | 7.26B | |
+21.27% | 3.84B | |
-8.78% | 3.43B | |
-24.45% | 1.31B | |
-35.53% | 1.11B | |
+2.79% | 919M | |
-24.21% | 856M | |
-39.85% | 840M |
- Stock Market
- Equities
- TRX Stock